Review of Factors Contributing to Nodular Goiter and Thyroid Carcinoma
- PMID: 31542786
- PMCID: PMC7024874
- DOI: 10.1159/000503575
Review of Factors Contributing to Nodular Goiter and Thyroid Carcinoma
Abstract
There is an increased incidence of thyroid nodules and cancer. In this article, the reasons for this increase are evaluated and discussed. The factors causing increases in the incidence of nodules are the same as those causing increases in thyroid cancer. There are publications from all over the world regarding the rising incidence of thyroid cancer; it is especially associated with papillary cancer. The literature was reviewed and evaluated with regard to this significant phenomenon. Thyroid-stimulating hormone (TSH) is the main mitotic factor. Any agent that elevates TSH will stimulate nodule formation. Therefore, the incidence of thyroid nodules is high in endemic goiter regions due to iodine deficiency. This paper has described many of the factors causing this higher incidence. Of note, metabolic syndrome and insulin resistance are important factors associated with the increased incidence of nodular goiter and papillary thyroid cancer today. However, these data must be confirmed by other studies in the future.
Keywords: Nodular goiter; Thyroid cancer.
© 2019 The Author(s) Published by S. Karger AG, Basel.
Conflict of interest statement
The authors declare no potential conflicts of interest.
Similar articles
-
The association between multinodular goiter and thyroid cancer.Minerva Endocrinol. 2010 Sep;35(3):187-92. Minerva Endocrinol. 2010. PMID: 20938421 Review.
-
Clinicopathological correlation of serum TSH in patients with thyroid nodule.J Indian Med Assoc. 2011 May;109(5):330, 335, 338. J Indian Med Assoc. 2011. PMID: 22187768
-
Nodular goiter and goiter nodules: Where iodine deficiency falls short of explaining the facts.Exp Clin Endocrinol Diabetes. 2001;109(5):250-60. doi: 10.1055/s-2001-16344. Exp Clin Endocrinol Diabetes. 2001. PMID: 11507648 Review.
-
Toxic nodular goiter and thyroid cancer: Is hyperthyroidism protective against thyroid cancer?Surgery. 2019 Sep;166(3):356-361. doi: 10.1016/j.surg.2019.03.012. Epub 2019 May 16. Surgery. 2019. PMID: 31104806
-
Pathogenesis of toxic thyroid adenomas and nodules: relevance of activating mutations in the TSH-receptor and Gs-alpha gene, the possible role of iodine deficiency and secondary and TSH-independent molecular mechanisms.Exp Clin Endocrinol Diabetes. 1998;106 Suppl 4:S6-9. doi: 10.1055/s-0029-1212048. Exp Clin Endocrinol Diabetes. 1998. PMID: 9867188 Review.
Cited by
-
Exploring the potential of genetic analysis in historical blood spots for patients with iodine-deficient goiter and thyroid carcinomas in Switzerland and Germany (1929-1989).BMC Med Genomics. 2024 Jun 28;17(1):171. doi: 10.1186/s12920-024-01947-y. BMC Med Genomics. 2024. PMID: 38943113 Free PMC article.
-
Benign nodules of the thyroid gland and 25-hydroxy-vitamin D levels in euthyroid patients.Ann Saudi Med. 2022 Mar-Apr;42(2):83-88. doi: 10.5144/0256-4947.2022.83. Epub 2022 Apr 7. Ann Saudi Med. 2022. PMID: 35380060 Free PMC article.
-
Thyroid Nodules and Obesity.Life (Basel). 2023 May 31;13(6):1292. doi: 10.3390/life13061292. Life (Basel). 2023. PMID: 37374075 Free PMC article. Review.
-
Predictive value of IGF-1/IGFBP-3 ratio for thyroid nodules in type 2 diabetic mellitus.Front Endocrinol (Lausanne). 2024 Oct 9;15:1444279. doi: 10.3389/fendo.2024.1444279. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39444449 Free PMC article.
-
Characteristics of Nodular Goitre and Its Correlation With Papillary Thyroid Carcinoma: A Cross-Sectional Study.Cureus. 2024 Nov 29;16(11):e74780. doi: 10.7759/cureus.74780. eCollection 2024 Nov. Cureus. 2024. PMID: 39737304 Free PMC article.
References
-
- Studer H, Peter HJ, Gerber H. Natural heterogeneity of thyroid cells: the basis for understanding thyroid function and nodular goiter growth. Endocr Rev. 1989 May;10((2)):125–35. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical